Springtime in the South. I call it “Sneezin’ Season” because the pollen drives my allergies into hyperactive overdrive. I take one sinus pill at 5:30 in the morning and a different medicine before I go to bed. These are the only medicines I take and they are different colors, different shapes, are in different packages […]
Continue reading about Medication Administration Records (MAR)s
Ampyra [am-PEER-ah], the brand name for a new drug named fampridine-SR, has been approved by the US Food and Drug Administration for the treatment of Multiple Sclerosis. The new drug is the first Multiple Sclerosis drug to enhance some neurological functioning for MS patients. Dr. Andrew Goodman, chief of the University of Rochester Medical Center’s […]
Continue reading about Ampyra, A New Multiple Sclerosis Drug with Promise